Lv6
1900 积分 2025-07-08 加入
TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
27天前
已完结
Pathophysiology of Inflammatory Bowel Diseases
27天前
已完结
Are all the IL-23 blockers the same in inflammatory bowel disease?
27天前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
30天前
已完结
Realizing the potential of agonistic antibody immunotherapy
30天前
已完结
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
1个月前
已完结
Gastrointestinal tuft cells: Recent insights and next questions
1个月前
已完结
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
1个月前
已完结
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
1个月前
已完结
Optimization of culture conditions for high-level expression of soluble and active tumor necrosis factor-α in E. coli
1个月前
已完结
皖公网安备34019202002308
